Program By Day

7:00 AM – 7:55 AM Poster Session B, With complimentary continental breakfast
7:00 AM – 8:05 AM

Breakout Session: Palliative and Supportive Care in the Immunotherapy Era

Thomas W. LeBlanc, MD, MA, MHS, FAAHPM – Chair
Duke Cancer Institute

Anand Mahadevan, MD – Chair
Geisinger Health System

Sandip P. Patel, MD
University of California, San Diego
Immunotherapy: New Developments and Challenges With Toxicity

Eric Roeland, MD, FAAHPM
University of California, San Diego

Jonathan D. Schoenfeld, MD
Brigham and Women's Cancer Center
Radioimmunotherapy: Current Status and Future Directions

Panel Question and Answer

8:10 AM – 9:45 AM

Welcome and General Session 4: Tough Issues in Opioid Management

Thomas J. Smith, MD, FACP, FASCO, FAAHPM – Chair
Johns Hopkins University School of Medicine

Susan Urba, MD – Chair
University of Michigan Cancer Center

Stephen T. Lutz, MD
Blanchard Valley Regional Cancer Center
Welcome of the Day

Eduardo Bruera, MD
The University of Texas MD Anderson Cancer Center
Methadone Challenges

Jeremy Hirst, MD
University of California, San Diego
My Patient Needs Opiates and Benzodiazepines: What Should I Do?

Jacob J. Strand, MD
Mayo Clinic, Rochester
Opioid Use Disorders

David Copenhaver, MD, MPH
University of California, Davis
Risk Tools and Opioid Contracts in Clinical Practice

Panel Question and Answer

9:45 AM – 10:15 AM Break
10:15 AM – 11:45 AM

Oral Abstract Session B


Petra Feyer, MD, PhD – Chair
Vivantes Clinics Neukoelln


Stephen T. Lutz, MD – Chair
Blanchard Valley Regional Cancer Center

Abstract 92: The positive effects of early integrated palliative care on patient coping strategies, quality of life, and depression. 
First author: Jamie Jacobs, PhD

Abstract 175: Randomized trial of a cognitive-behavioral therapy mobile app for anxiety in patients with incurable cancer. 
First author: Joseph Greer, PhD

Gary Rodin, MD
Princess Margaret Cancer Centre

Abstract 203: The effect of nurse-led pain education of patients with painful bone metastases on pain and quality of life: A multicenter randomized trial. 
First author: Jenske Geerling


Abstract 176: The "Promoting Resilience in Stress Management" (PRISM) intervention for adolescents and young adults: A pilot randomized controlled trial.  
First author: Abby Rosenberg, MD, MS

Christina Ullrich, MD
Dana-Farber Cancer Institute

Panel Question and Answer

11:45 AM – 1:15 PM

Poster Session B, Continued
With complimentary boxed lunch

12:00 PM – 1:00 PM

Conversation Cafe
For more information, visit Networking Opportunities

1:15 PM – 2:00 PM

Keynote Lecture

Tracy Balboni, MD, MPH – Chair
Dana-Farber Cancer Institute

Anthony Back, MD
Seattle Cancer Care Alliance
Clinician Burnout: Why We Need a Multi-level, Multi-stakeholder Response

2:00 PM – 3:30 PM

General Session 5: Intimacy Matters—Sexual Health and Palliative Care

Jeannine M. Brant, PhD, APRN, AOCN, FAAN – Chair
Billings Clinic

Candice A. Johnstone, MD, MPH – Chair
Medical College of Wisconsin

Anne Katz, PhD, RN, FAAN
Cancer Care Manitoba
Talking About Sexuality With Patients: Models, Myths, and Motivations

Sharon Bober, PhD
Dana-Farber Cancer Institute
Research in Sexual Health and Body Image

Erin E. Stevens, MD, FACOG
Billings Clinic
Interventions to Facilitate Sexual Health


Abstract 191: A multimodal intervention to enhance sexual function and quality of life (QOL) in hematopoietic stem cell transplant (HCT) survivors.
First author, Areej El-Jawahri, MD

Panel Question and Answer

3:30 PM – 4:00 PM Break
4:00 PM – 5:30 PM

General Session 6: Roles and Risks of Local Interventions—Palliative Radiation Therapy and Palliative Surgery

Candice A. Johnstone, MD, MPH – Chair
Medical College of Wisconsin

Kavita V. Dharmarajan, MD, MSc – Chair
Mount Sinai Hospital

Candice A. Johnstone, MD, MPH
Medical College of Wisconsin
ARS Introduction and Indications for Palliative Radiotherapy and Myth Busting in Hypofractionated Radiotherapy

Brian D. Badgwell, MD
The University of Texas MD Anderson Cancer Center
The Pros and Cons of Palliative Surgical Interventions

Panel Discussion: Brain Metastasis: To Treat or Not To Treat?

Anand Mahadevan, MD
Geisinger Health System

Timothy J. Moynihan, MD
Mayo Clinic, Rochester

Panel Question and Answer